A focused course, tailored for you
Audit-Ready Software Validation for Enterprise QA
Build the test evidence packages regulated customers accept on first review.
Enterprise QA engineers produce thorough test documentation. Regulated customers reject it anyway, because the evidence format doesn't match what their validation team needs to close the protocol. The gap is learnable and specific.
$199 one-time
Tailored to your situation. Access within 24 hours. 30-day money-back.
Includes a hand-built implementation playbook delivered alongside course access, generated for your specific situation.
Why this course
A Senior QA Engineer at an enterprise software company runs structured regression cycles, logs defects with detail, and closes releases on schedule. But when a pharma, finance, or utilities customer sends the test summary back for a second review, the feedback is rarely about test coverage. It is about traceability: the test script that doesn't reference the validation requirement by identifier, the deviation record missing the root-cause sign-off box, the IQ summary that reads like an internal release note rather than a protocol execution record. These gaps cost days of rework per release and erode the customer's confidence in the go-live timeline. The skill that closes the gap is not more testing. It is knowing what evidence a regulated customer's QA lead needs to sign the protocol, and building that evidence into the documentation from the first test execution, not as a retrofit before handover.
The 12 modules
Module 1. What Regulated Customers Actually Review
Maps the difference between internal QA documentation and the validation artefacts a regulated customer's QA lead is required to review before protocol sign-off. Covers the regulatory frameworks that drive the requirement: 21 CFR Part 11 for pharma and medical device, SOX Section 404 for financial software, NERC CIP for utilities. Explains why the same test can satisfy your release gate but not their validation protocol, and which document elements create the divergence.
Module 2. Requirements Traceability: From Test Script to Regulation
Builds a working requirements traceability matrix (RTM) for a software module in a regulated deployment. Covers the three-layer trace: from regulatory requirement to functional specification to test script identifier. Shows the specific column format that a 21 CFR Part 11 or SOX auditor expects to see, including how to handle requirements that map to multiple test scripts and test scripts that cover partial requirements. Includes a downloadable RTM template formatted to the FDA and PCAOB review standards.
Module 3. Deviation Records That Close Without Rework
Explains why deviation records written for an internal defect tracker fail a regulated customer's protocol review. Covers the five mandatory fields a GxP deviation record must contain: problem statement in validated-system language, impact assessment scoped to the validated function, root cause with evidence reference, corrective action with completion date, and QA approval sign-off. Walks through rewriting a standard defect log entry into a deviation record that a pharma validation manager can accept without requesting additional documentation.
Module 4. IQ, OQ, PQ Protocol Summaries
Covers the three-phase validation protocol structure required for software in GxP environments: Installation Qualification, Operational Qualification, and Performance Qualification. Explains what each phase must document and what an auditor checks during each review. Focuses on the protocol summary document, which is the artefact most frequently returned for rework because enterprise QA teams write it as a release note rather than as a formal protocol execution record. Includes annotated examples of passing and failing protocol summaries.
Module 5. SOX Test Evidence for Financial Software Modules
Maps the PCAOB and SOX Section 404 test evidence requirements to the modules most commonly tested by enterprise software QA teams: financial close workflows, access control, segregation of duties, and audit log integrity. Covers what a SOX auditor asks to see during an IT general controls review and how to produce test evidence that satisfies those requests without a separate documentation effort. Explains the difference between functional and IT control test evidence, and how to write scripts that generate both.
Module 6. Test Plan Architecture for Regulated Deployments
Redesigns the standard enterprise QA test plan for a regulated customer deployment. Covers the sections a pharma or financial auditor expects but most enterprise test plans omit: validation scope statement, exclusions with written rationale, protocol approval signature block, and the validation master plan reference. Shows how to adapt an existing test plan template to pass a pre-go-live review without rebuilding from scratch. Includes a before-and-after comparison on a real enterprise software test plan.
Module 7. Managing the Customer's Validation Review Cycle
Covers the process side of the regulated customer review: how to structure the review submission package, what to include in the cover note, how to track open review comments against protocol references, and how to communicate closure evidence without triggering a new review cycle. Explains the most common reasons a second review cycle is requested (missing evidence reference, unclear deviation closure, ambiguous test scope statement) and how to close each one at submission rather than in the follow-up.
Module 8. Automated Test Scripts in Regulated Environments
Addresses the compliance documentation gap that appears when QA teams migrate to automated test execution: the test script artefact that an auditor reviews is no longer a human-readable step-by-step document but a code file. Covers how to produce an execution summary that satisfies a validation protocol reviewer, how to document the automation framework itself as a validated tool, and how to handle test script versioning in a way that maintains the traceability matrix when scripts are updated between releases.
Module 9. Defect Triage in Validated Systems
Explains how defect triage decisions in a validated system carry a documentation obligation absent from standard QA practice. Covers the risk assessment a regulated customer expects when a defect is deferred: impact on validated function, interim control, and expected closure date referenced to a future protocol revision. Shows how to write a triage decision record that satisfies a QA auditor's query about deferred defects, using examples from enterprise software deployments in pharmaceutical manufacturing.
Module 10. Change Control Documentation for Software Updates
Covers the change control documentation a regulated customer requires before accepting a software update into their validated environment. Maps the enterprise release note to the change control record format, covering impact assessment, revalidation scope, and regression test evidence summary. Explains the difference between a minor change requiring a summary assessment and a major change requiring a full revalidation protocol, and how to make that determination in writing the customer's QA team will accept.
Module 11. Building a Reusable Documentation Template Set
Assembles the artefacts from the prior modules into a reusable documentation template set for regulated customer projects. Covers how to version and maintain the templates, how to tailor them for a specific regulatory sector without rebuilding from scratch, and how to run a team onboarding session so all QA engineers on a project produce consistent artefacts. Includes guidance on storing templates in a document control system that satisfies a pharma auditor's version history request.
Module 12. Pre-Go-Live Validation Package Review
Walks through the complete pre-go-live validation package review a QA engineer conducts before handing documentation to the customer's validation team. Covers the artefact checklist for a typical regulated deployment, the common gaps found at this stage, and how to resolve each one without delaying go-live. Ends with a self-review protocol the participant can run on their next project to catch documentation gaps before the customer review cycle and shorten the time between test completion and protocol sign-off.
How this addresses your situation
Specific modules that map to what you said you are dealing with.
Pharma customer returns test summary for second review because deviation closure evidence doesn't trace to protocol reference: Modules 3, 4, 7.
SOX auditor requests IT general controls test evidence not present in the standard QA output: Modules 5, 6.
Automated test scripts fail the validation protocol review because the artefact is a code file, not a readable test step document: Module 8.
Regulated customer accepts the software but places a condition on the change control documentation for future updates: Modules 10, 11.
What happens if you do not address this
Each rework cycle before a regulated customer go-live costs time, erodes the customer relationship, and signals that the QA team does not understand their compliance environment. As more enterprise software is deployed into regulated sectors, QA engineers who cannot produce audit-ready validation documentation become a bottleneck on every regulated project. The skill gap is specific and learnable, but it does not close through trial and error on customer projects.
Who it is for
Senior QA engineers and test leads at enterprise software companies whose customers operate in regulated sectors: pharmaceuticals, medical devices, financial services, utilities, manufacturing. You run structured release cycles and produce detailed documentation. The issue is not volume or diligence. It is that your customers' validation teams need specific artefact formats you were never trained to produce, and learning them piecemeal through rejection cycles is slow and demoralising.
Who this is NOT for. QA engineers whose customers do not operate in regulated sectors. Independent testers working on consumer software. Anyone whose QA documentation is already reviewed and accepted by a pharma or SOX compliance team without revision requests.
How it arrives
Text-based course in the Art of Service learning environment, plus downloadable templates and worked examples for every module, plus the hand-built implementation playbook delivered alongside course access.
Time investment. 12 modules, approximately 30-45 minutes each. Most participants complete the documentation-focused modules 1-7 in the first week and apply them to an active project before completing modules 8-12.
Why $199 is the right number
A formal computer system validation (CSV) training course typically costs $1,500-$3,000, covers the regulatory framework in depth, but does not address the documentation artefact format gap specific to enterprise software QA teams. An internal project learning approach costs nothing upfront but extends across multiple rework cycles and customer escalations. This course targets the specific artefact gap at a fraction of the cost of a full CSV programme.
FAQ
Does this course apply to SAP-specific products or is it framework-agnostic?
The documentation principles are framework-agnostic and apply to any enterprise software deployed into a regulated environment. The implementation playbook is tailored to your specific stack and customer context at purchase.
My customers are in financial services, not pharma. Does the SOX content cover what I need?
Module 5 covers SOX IT general controls test evidence specifically. The traceability and change control modules apply directly to financial software deployments. The pharma-specific content in modules 4 and 9 is labelled as sector-specific and can be skipped if your customer base is purely financial.
We use an automated test framework. Is this course still relevant?
Yes. Module 8 covers the specific documentation gap that automated test execution creates in a regulated environment and how to produce an execution summary that satisfies a protocol reviewer.
